as 09-15-2025 3:20pm EST
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
Founded: | 2008 | Country: | United States |
Employees: | N/A | City: | SALT LAKE CITY |
Market Cap: | 90.6M | IPO Year: | 2021 |
Target Price: | N/A | AVG Volume (30 days): | 109.9K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.83 | EPS Growth: | N/A |
52 Week Low/High: | $1.37 - $9.13 | Next Earning Date: | 11-05-2025 |
Revenue: | $108,000 | Revenue Growth: | 0.94% |
Revenue Growth (this year): | 257.66% | Revenue Growth (next year): | 435.22% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Boniface John J. | SERA | Chief Scientific Officer | Sep 11 '25 | Sell | $3.13 | 1,395 | $4,366.35 | 159,493 | |
Lindgardt Zhenya | SERA | Chief Executive Officer | Sep 11 '25 | Sell | $3.13 | 3,246 | $10,159.98 | 807,890 | |
Kearney Paul | SERA | Chief Data Officer | Sep 11 '25 | Sell | $3.13 | 1,271 | $3,978.23 | 175,669 | |
Jackson Benjamin | SERA | General Counsel | Sep 11 '25 | Sell | $3.13 | 934 | $2,923.42 | 126,817 | |
Aerts Austin | SERA | Chief Financial Officer | Sep 11 '25 | Sell | $3.13 | 915 | $2,863.95 | 284,670 | |
Harrison Robert Gardner | SERA | Chief Information Officer | Sep 11 '25 | Sell | $3.13 | 645 | $2,018.85 | 99,932 | |
Lindgardt Zhenya | SERA | Chief Executive Officer | Sep 9 '25 | Sell | $3.15 | 21,158 | $66,647.70 | 807,890 | |
Aerts Austin | SERA | Chief Financial Officer | Sep 9 '25 | Sell | $3.15 | 5,263 | $16,578.45 | 284,670 | |
Lawrence Sandra AJ | SERA | Director | Sep 9 '25 | Sell | $3.05 | 3,899 | $11,891.95 | 18,814 | |
Harrison Robert Gardner | SERA | Chief Information Officer | Sep 9 '25 | Sell | $3.05 | 2,000 | $6,100.00 | 99,932 |
SERA Breaking Stock News: Dive into SERA Ticker-Specific Updates for Smart Investing
Simply Wall St.
3 months ago
Investopedia
4 months ago
GlobeNewswire
4 months ago
GlobeNewswire
4 months ago
Benzinga
4 months ago
GlobeNewswire
4 months ago
GlobeNewswire
4 months ago
GlobeNewswire
4 months ago
The information presented on this page, "SERA Sera Prognostics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.